相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Protein kinase CK2 in hematologic malignancies: reliance on a pivotal cell survival regulator by oncogenic signaling pathways
F. Piazza et al.
LEUKEMIA (2012)
Update on Therapy of Chronic Lymphocytic Leukemia
John G. Gribben et al.
JOURNAL OF CLINICAL ONCOLOGY (2011)
Targeting CK2 overexpression and hyperactivation as a novel therapeutic tool in chronic lymphocytic leukemia
Leila R. Martins et al.
BLOOD (2010)
Reconstitution of PTEN activity by CK2 inhibitors and interference with the PI3-K/Akt cascade counteract the antiapoptotic effect of human stromal cells in chronic lymphocytic leukemia
Medhat Shehata et al.
BLOOD (2010)
CX-4945, an Orally Bioavailable Selective Inhibitor of Protein Kinase CK2, Inhibits Prosurvival and Angiogenic Signaling and Exhibits Antitumor Efficacy
Adam Siddiqui-Jain et al.
CANCER RESEARCH (2010)
Treatment of patients with fludarabine-refractory chronic lymphocytic leukemia: need for new treatment options
Apostolia-Maria Tsimberidou et al.
LEUKEMIA & LYMPHOMA (2010)
Treatment of B-cell chronic lymphocytic leukemia with nonchemotherapeutic agents: experience with single-agent and combination therapy
S. Faderl et al.
LEUKEMIA (2009)
The Akt signaling pathway determines the different proliferative capacity of chronic lymphocytic leukemia B-cells from patients with progressive and stable disease
P. G. Longo et al.
LEUKEMIA (2007)
Mechanisms of apoptosis-induction by rottlerin: therapeutic implications for B-CLL
I Ringshausen et al.
LEUKEMIA (2006)
Protein kinase CK2 phosphorylates and upregulates Akt/PKB
G Di Maira et al.
CELL DEATH AND DIFFERENTIATION (2005)
A sustained activation of PI3K/NF-κB pathway is critical for the survival of chronic lymphocytic leukemia B cells
S Cuní et al.
LEUKEMIA (2004)
分享论文
